Nevertheless, this methodology can also be used to model all cellular mechanisms to evaluate potential undesired off-target and side effects as well as to the identification of new disease-related genes, such as GABRA, GRIN1, KCC or SLC12A5 whose mutations can lead to the development of retinal dystrophies. This evidence concerns the gene SLC12A5 and Retinal dystrophy.